Prognostic Nomogram for Mixed Endometrial Carcinoma Patients
Author Information
Author(s): Kang Luyao, Ji Gaili, Zhang Nan, Meng Jie, Liu Duan, Li Hongyu
Primary Institution: The Third Affiliated Hospital of Zhengzhou University
Hypothesis
What are the independent prognostic factors and optimal treatment modalities for mixed endometrial carcinoma patients treated with hysterectomy?
Conclusion
The study successfully built and validated a nomogram that can effectively predict the prognosis of mixed endometrial carcinoma patients treated with hysterectomy.
Supporting Evidence
- The nomogram showed good discrimination with C-indices of 0.807 for overall survival and 0.834 for cancer-specific survival.
- Chemotherapy improved prognosis in high-risk groups with positive lymph nodes.
- Radiotherapy was associated with better outcomes in intermediate and high-risk groups.
Takeaway
Doctors created a special chart to help predict how well patients with a certain type of cancer will do after surgery, which can help them choose the best treatment.
Methodology
The study used the SEER database to analyze 12,848 mixed endometrial carcinoma patients treated with hysterectomy, identifying prognostic factors through Cox regression analysis.
Potential Biases
Potential selection bias and unknown confounding variables due to the retrospective nature of the study.
Limitations
The study is retrospective, which may introduce selection and recall bias, and lacks detailed chemotherapy information and diversity in the patient population.
Participant Demographics
Patients included were primarily American white women diagnosed with mixed endometrial carcinoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website